|Systematic (IUPAC) name|
|Routes||Oral, rectal (enema)|
|ATC code||A06 A06|
|Molecular mass||240.211 g/mol|
|(what is this?)|
Dantron (INN), also known as chrysazin or 1,8-dihydroxyanthraquinone, is an organic substance, formally derived from anthraquinone by the replacement of two hydrogen atoms by hydroxyl groups (–OH). It is used in some countries as a stimulant laxative.
In the UK it is considered a possible carcinogen and so its licence is restricted to patients who already have a diagnosis of terminal cancer. It is mainly used in palliative care to counteract the constipating effects of opioids. Its British Approved Name was danthron, but it has now been changed to "dantron", the recommended International Nonproprietary Name.
Dantron has the notable side-effect of causing red-colored urine.
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|